The Drug Enforcement Administration this week proposed changing rules that govern the amount of prescription opioids that drug manufacturers can produce each year. The changes could sharply reduce the annual production of opioids, Reuters reports.
The acting chief of the Drug Enforcement Administration told the House Energy and Committee this week the agency is doing a better job of tracking the flow of opioid painkillers from manufacturers to pharmacies, The Washington Post reports.
Purdue Pharma, the maker of OxyContin, said it will no longer market the drug to doctors. The announcement comes in response to lawsuits that blame the company for helping to trigger the opioid crisis, CBS News reports.
President Trump’s opioid commission last week focused on health insurance companies’ role in contributing to the addiction crisis. The commission is scheduled to deliver its final report on November 1.
Representative Tom Marino of Pennsylvania announced this week he is withdrawing his name from consideration as head of the White House Office of National Drug Control Policy. His decision comes in the wake of a Washington Post and 60 Minutes joint report that concluded legislation Marino sponsored hampered efforts by the Drug Enforcement Administration to fight the opioid epidemic.
Health insurer Cigna announced this week it will stop covering the prescription opioid OxyContin in an effort to reduce inappropriate use of the drug. Instead it will cover an equivalent drug less vulnerable to being misused.
Drug company and government officials announced new efforts designed to fight opioid addiction during a meeting this week of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
President Trump this week promised to win the fight against the opioid epidemic, but declined to act on a recommendation to declare a national emergency. He offered no new recommendations, Reuters reports.